Advertisement
Loading...

MERCK Kommanditgesellschaft auf Aktien

MKKGYPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$30.47
$0.40(1.33%)
U.S. Market is Open • 14:55
Advertisement

MERCK Kommanditgesellschaft auf Aktien (MKKGY) Stock Overview

Explore MERCK Kommanditgesellschaft auf Aktien’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap65.9B
P/E Ratio22.32
EPS (TTM)$1.37
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$25.93
3 Months$32.20
1 Year Target$25.08

MKKGY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of MERCK Kommanditgesellschaft auf Aktien (MKKGY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 70.90, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $25.08.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 22.32 and a market capitalization of 65.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.06%
5-Day Change
1.10%
1-Month Change
16.08%
3-Month Change
-0.10%
6-Month Change
12.60%
Year-to-Date (YTD) Change
5.96%
1-Year Change
16.30%
3-Year Change
-13.88%
5-Year Change
-15.42%
All-Time (Max) Change
151.99%

Contact Information

49 6151 72 0
Frankfurter Strasse 250, Darmstadt, NaN, 64293

Company Facts

59,020 Employees
IPO DateNov 16, 2007
CountryDE
Actively Trading

Frequently Asked Questions